Back to search
FDAFDA · Food and drugs·Recall number D-1439-2019

Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01

Published July 10, 2019 · Recall initiated: September 25, 2017

Summary

FDA records drug Class III recall D-1439-2019, published July 10, 2019 and initiated September 25, 2017. Recalling firm: Amneal Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 19176 units; Lot: Lot #: HL06015, HL06115, Exp. 10/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amneal Pharmaceuticals, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: HL06015, HL06115, Exp. 10/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01 recalled?

Yes. FDA published recall D-1439-2019 on July 10, 2019. Reported hazard: Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter